The Rising Prevalence Of COPD To Boost Spirometer Market Growth
Spirometer Market |
The
Spirometer Market is Segmented by
Type (Hand-Held, and Table-Top), Technology (Volume Measurement, and Flow
Measurement), Application (Asthma, COPD, Cystic Fibrosis, and Others), End-User
(Hospitals and Clinics, and Home Healthcare) and by Region (Europe, North
America, Asia Pacific, Africa, Latin America and Middle East) - Size, Share,
Outlook, and Opportunity Analysis, 2023 – 2030
The
global spirometer market is estimated to be valued at US$ 958.0 million in 2021
and is expected to exhibit a CAGR of 9.5% over the forecast period (2021-2028),
as highlighted in a new report published by Coherent Market Insights.
Market Overview:
A
Spirometer is a medical
equipment that evaluates the quantity of air one is capable to inhale and
exhale. It also traces the timespan it takes for the individual to breathe out
completely post one is taking a deep breath. A spirometry test necessitates one
to breathe into a catheter linked to a machine known as a spirometer.
Competitive Landscape:
Key Players involved in the growth of the global Spirometer
Market are
Koninklijke Philips N.V., MGC Diagnostics Corporation, KoKo PFT, NDD Medical
Technologies and ICU Medical, Inc.
Market Key Drivers:
The
rising prevalence of COPD is expected to augment the growth of global
Spirometers Market. For instance, as per WHO, above 65 million suffer from COPD
across the globe.
Technical
developments and the rising convenience and convenience of operation of
equipment are projected to boost the growth of the global Spirometer Market. For instance, in March 2021, the AioCare was
launched by Vyaire Medical in above 15 countries, involving Australia and other
regions.
Covid-19 Impact Analysis:
The
COVID-19 outbreak has adversely affected the growth of the global spirometer
market as there was a decline in the analysis and cure of individuals suffering
from respiratory disorders. For instance, as per Elsevier Public Health
Emergency, in September 2021, it has been monitored that the usage of
spirometry is limited to immunocompromised individuals for urgent therapeutics
only, such as bone marrow grafts, lung implantation, and pre-chemotherapy therapeutics.
Key Takeaways:
For
instance, as per WHO, above 80% of the global 1.3 billion tobacco consumers
live in low- and middle-income regions.
Among
regions, North America, Europe, and Asia Pacific are expected to witness robust
growth in the global spirometer market due to rise in cases of COPD, increasing
asthma cases, increasing smokers and rising collaborations and partnerships.
For instance, as per AAFA, in April 2022, around 1 in 13 Americans suffer from
asthma, which is around 25 million people in U.S.
Comments
Post a Comment